Msn Laboratories
Msn Laboratories, officially known as Msn Laboratories Pvt. Ltd., is a prominent player in the pharmaceutical industry, headquartered in India. Established in 2003, the company has rapidly expanded its operations across major regions, including Europe, the Americas, and Asia, solidifying its position in the global market. Specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, Msn Laboratories is recognised for its commitment to quality and innovation. The company’s core products include a diverse range of therapeutic solutions, particularly in the fields of oncology, cardiology, and anti-infectives, setting it apart with its robust research and development capabilities. With a strong market presence, Msn Laboratories has achieved several milestones, including regulatory approvals from major health authorities, which underscores its dedication to excellence and reliability in the pharmaceutical sector.
DitchCarbon Score
How does Msn Laboratories's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Msn Laboratories's score of 12 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Msn Laboratories's reported carbon emissions
In 2023, Msn Laboratories reported total carbon emissions of approximately 209,090,370 kg CO2e, with Scope 1 emissions accounting for about 109,040,650 kg CO2e and Scope 2 emissions at approximately 83,016,740 kg CO2e. The following year, 2024, emissions increased, with Scope 1 emissions reaching about 135,767,630 kg CO2e, Scope 2 emissions rising to approximately 126,073,600 kg CO2e, and Scope 3 emissions reported at about 66,735,710 kg CO2e. Despite these figures, Msn Laboratories has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or science-based targets suggests a need for enhanced commitment to sustainability practices within the industry context. As a significant player in the pharmaceutical sector, Msn Laboratories' emissions profile highlights the importance of addressing climate change through effective strategies and measurable goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 109,040,650 | 000,000,000 |
| Scope 2 | 83,016,740 | 000,000,000 |
| Scope 3 | - | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Msn Laboratories is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
